SAN DIEGO (AP) — SAN DIEGO (AP) — Kura Oncology Inc. (KURA) on Tuesday reported a loss of $70.2 million in its third quarter.

The San Diego-based company said it had a loss of 78 cents per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 83 cents per share.

The biopharmaceutical company posted revenue of $22.8 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $22.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KURA at https://www.zacks.com/ap/KURA